日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma

伊伐替诺他联合吉西他滨和厄洛替尼治疗未经治疗的局部晚期或转移性胰腺腺癌患者的 I/II 期临床研究

Jung Hyun Jo, Dawoon E Jung, Hee Seung Lee, Soo Been Park, Moon Jae Chung, Jeong Youp Park, Seungmin Bang, Seung Woo Park, Sangsook Cho, Si Young Song

HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment

HDAC抑制剂CG-745通过调节免疫微环境增强抗PD-1免疫检查点抑制剂的抗癌作用

Young-Dae Kim ,Sang-Min Park ,Hae Chan Ha ,A Reum Lee ,Heeyoung Won ,Hyunju Cha ,Sangsook Cho ,Joong Myung Cho